NCSTN and hepatocellular carcinoma: Intriguingly, several studies have proven that genome-wide liver carcinoma screening identified NCSTN as one of the 50 potential driver genes [11], and NCSTN is abnormally upregulated and frequently amplified in liver cancer [12].